News that an experimental drug seems to be the first effective treatment for the new coronavirus has unleashed a flurry of interest - and a clamor to know how soon it might be available. Talk turned ...
For the first time, a major study suggests that an experimental drug works against the new coronavirus, and U.S. government officials said Wednesday that they would work to make it available to ...
Scientists discover how remdesivir works to inhibit coronavirus University of Texas at Austin Journal Molecular Cell Funder ...
With a coronavirus vaccine at least a year away, some scientists are investigating existing medicines and compounds that might work as effective treatments. A drug called remdesivir is now in the ...
President Donald Trump is receiving an experimental antiviral for Covid-19 called remdesivir as he remains hospitalized at Walter Reed National Military Medical Center in Bethesda, Maryland. The drug ...
For the first time, a major study suggests that an experimental drug works against the new coronavirus, and U.S. government officials said Wednesday that they would work to make it available to ...
The U.S. Food and Drug Administration has approved the use of the antiviral drug remdesivir for children ages 28 days and older. With the decision, the drug becomes the first approved treatment for ...
Gilead Sciences has said it will soon start clinical trials for inhaled formulation of its antiviral drug remdesivir used for the treatment of Covid-19. The US drugmaker said the trials will begin in ...
New research shows for the first time why the antiviral drug remdesivir works against some viruses but not others—a finding that improves our understanding of how antiviral drugs interact with viruses ...
MARTINEZ, Calif. -- Imagine a lottery deciding whether you get medicine for the coronavirus. That's the conversation happening at health departments for how to decide who gets remdesivir. This drug is ...
Something the article doesn't draw attention to is that the study run by NIAID/NIH studying Remdesivir in the hospital environment was a double blinded random controlled test. And it showed strong ...
Associate Professor Wheate in the past has received funding from the ACT Cancer Council, Tenovus Scotland, Medical Research Scotland, Scottish Crucible, and the Scottish Universities Life Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback